| Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children (NCT01504841) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-14 |
| Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults (NCT01797445) | Gilead Sciences | 2013-03-12 |
| HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin (NCT01718301) | Anna Cruceta | 2013-03-10 |
| Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers (NCT01705990) | International AIDS Vaccine Initiative | 2013-03-01 |
| A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects (NCT01850212) | Gilead Sciences | 2013-02-01 |
| Prevalence of Thyroid Function Abnormalities in HIV-infected Patients (NCT03149354) | Centre Hospitalier Universitaire, Amiens | 2013-01-28 |
| Exploration of the Neo-Vagina Study (NCT03049371) | Thai Red Cross AIDS Research Centre | 2013-01-01 |
| European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol (NCT04677842) | PENTA Foundation | 2013-01-01 |
| Neurocognitive Effects of Opiate Agonist Treatment (NCT01733693) | Albert Einstein College of Medicine | 2013-01-01 |
| Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults (NCT01780506) | Gilead Sciences | 2012-12-26 |
| Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents (NCT01721109) | Gilead Sciences | 2012-12-06 |
| Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women (NCT01705574) | Gilead Sciences | 2012-10-24 |
| A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007) (NCT01632345) | Merck Sharp & Dohme LLC | 2012-10-12 |
| Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials (NCT01618058) | International Partnership for Microbicides, Inc. | 2012-10-04 |
| Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics (NCT01632995) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-10-01 |
| Open Label Extension (OLE) of the TDF2 Study, Botswana (NCT04318210) | Centers for Disease Control and Prevention | 2012-10-01 |
| Safer Sex Program for Young African-American Men (NCT01439503) | Richard Crosby | 2012-09-01 |
| The Mochudi Prevention Project ART Protocol (NCT01583439) | Harvard School of Public Health (HSPH) | 2012-09-01 |
| Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine (NCT01641809) | ViiV Healthcare | 2012-08-06 |
| Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults (NCT01799954) | HIV Vaccine Trials Network | 2012-08-01 |
| Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women (NCT01617096) | International Partnership for Microbicides, Inc. | 2012-07-24 |
| Intervention Development for Social Stress, Mental Health, and HIV Risk MSM (NCT02448186) | Yale University | 2012-07-01 |
| A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247) (NCT01622673) | Merck Sharp & Dohme LLC | 2012-06-01 |
| Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults (NCT01578889) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-01 |
| Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir (NCT01568892) | ViiV Healthcare | 2012-04-18 |
| D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults (NCT01565850) | Gilead Sciences | 2012-04-01 |
| Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults (NCT01571960) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144 (NCT01435135) | U.S. Army Medical Research and Development Command | 2012-04-01 |
| Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV (NCT01433185) | University of Washington | 2012-04-01 |
| Screening, Brief Intervention, and Referral to Treatment for Offenders (NCT01683643) | University of California, Los Angeles | 2012-04-01 |
| Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection (NCT01482767) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women (NCT01539226) | International Partnership for Microbicides, Inc. | 2012-03-27 |
| Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice (NCT01524900) | Boehringer Ingelheim | 2012-03-01 |
| Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients (NCT01546818) | Sumagen | 2012-03-01 |
| Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women (NCT01461096) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-03-01 |
| Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS (NCT01349062) | Traditional Alternative Medicine Research, India | 2012-02-27 |
| Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya (NCT01425073) | University of Washington | 2012-02-01 |
| Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (NCT01533259) | Gilead Sciences | 2012-01-01 |
| Evaluation of the Population-level Impact of PMTCT Option B+ in Zimbabwe (NCT03388398) | University of California, Berkeley | 2012-01-01 |
| Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV (NCT05215704) | Erasmus Medical Center | 2012-01-01 |
| A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients (NCT01638650) | Hoffmann-La Roche | 2012-01-01 |
| Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults (NCT01497899) | Gilead Sciences | 2011-12-28 |
| Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (NCT01495702) | Gilead Sciences | 2011-12-01 |
| Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults (NCT01479296) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers (NCT01511237) | Institut de Recherche pour le Developpement | 2011-12-01 |
| Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers (NCT01496989) | International AIDS Vaccine Initiative | 2011-12-01 |
| Vitamin D Supplementation in HIV Youth (NCT01523496) | University Hospitals Cleveland Medical Center | 2011-12-01 |
| Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring (NCT01363037) | International Partnership for Microbicides, Inc. | 2011-11-01 |
| Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients (NCT01475838) | Gilead Sciences | 2011-11-01 |
| Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults (NCT01438606) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-10-01 |
| Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe (NCT01956396) | Ministry of Health and Child Welfare, Zimbabwe | 2011-10-01 |
| Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting (NCT01053598) | Epicentre | 2011-09-01 |
| Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults (NCT01440569) | Gilead Sciences | 2011-09-01 |
| Computerized Counseling to Promote Positive Prevention and HIV Health in Kenya (NCT01015989) | New York University | 2011-09-01 |
| Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102) (NCT01423825) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine (NCT01407497) | Instituto Nacional de Saúde, Mozambique | 2011-08-01 |
| Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. (NCT01011413) | Kirby Institute | 2011-08-01 |
| The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP) (NCT01327651) | HIV Prevention Trials Network | 2011-08-01 |
| Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir (NCT01288417) | Radboud University Medical Center | 2011-08-01 |
| Drug Exposure Registry for GSK2248761, an Investigational NNRTI (NCT01458132) | ViiV Healthcare | 2011-07-29 |
| A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa (NCT01337583) | International Partnership for Microbicides, Inc. | 2011-07-01 |
| A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa (NCT01337570) | International Partnership for Microbicides, Inc. | 2011-07-01 |
| Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials (NCT01376726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-07-01 |
| Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine (NCT01285141) | St George's, University of London | 2011-07-01 |
| Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485) (NCT01151189) | Aeras | 2011-07-01 |
| Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers (NCT01374802) | Boehringer Ingelheim | 2011-06-01 |
| The SOLVE-IT National Randomized Trial (NCT00653991) | University of Southern California | 2011-06-01 |
| Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001) (NCT01335191) | Thymon, LLC | 2011-06-01 |
| Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants (NCT01828073) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-19 |
| Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost (NCT01645865) | Elizabeth Glaser Pediatric AIDS Foundation | 2011-05-01 |
| Isentress Re-examination Study (MK-0518-115) (NCT01042808) | Merck Sharp & Dohme LLC | 2011-05-01 |
| Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment (NCT01363011) | Gilead Sciences | 2011-05-01 |
| Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users (NCT01343654) | University of Virginia | 2011-05-01 |
| Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) (NCT01159223) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-05-01 |
| Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals (NCT00955006) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents (NCT01302847) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-20 |
| Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru (NCT02630082) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Drug Drug Interaction of BI 201335 and Tenofovir (NCT01340196) | Boehringer Ingelheim | 2011-04-01 |
| Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and Breastfeeding (NCT01066858) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-22 |
| Tenofovir Gel in Pregnancy and Lactation (NCT01136759) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients (NCT01318096) | Yunnan AIDS Care Center | 2011-03-01 |
| Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries (NCT01061151) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults (NCT01266616) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir (NCT01294761) | National Center for Global Health and Medicine, Japan | 2011-02-01 |
| Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines (NCT01264445) | International AIDS Vaccine Initiative | 2011-02-01 |
| TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir (NCT01288755) | Tibotec Pharmaceuticals, Ireland | 2011-02-01 |
| Structured Treatment Interruption (STI) in Acute/Primary HIV (NCT01293513) | Tel-Aviv Sourasky Medical Center | 2011-02-01 |
| Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks (NCT01218802) | University Hospitals Cleveland Medical Center | 2011-02-01 |
| Risk Taking Behaviour in MSM and the Denial of Sexually Transmitted Diseases and HIV (NCT01279005) | Rambam Health Care Campus | 2011-02-01 |
| Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants (NCT01082692) | Inovio Pharmaceuticals | 2011-01-01 |
| Antigenic Competition in HIV Preventive Vaccines (NCT01159990) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-01 |
| Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers. (NCT01276990) | Boehringer Ingelheim | 2011-01-01 |
| Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection (NCT01273142) | Henan Provincial People's Hospital | 2011-01-01 |
| Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort (NCT06107140) | Tourcoing Hospital | 2011-01-01 |
| A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium (NCT01242579) | International Partnership for Microbicides, Inc. | 2011-01-01 |
| Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa (NCT03458338) | University Hospital, Basel, Switzerland | 2010-12-08 |
| GSK1349572 Hepatic Impairment Study (NCT01231529) | ViiV Healthcare | 2010-11-19 |
| Cryptococcal Optimal ART Timing Trial (NCT01075152) | University of Minnesota | 2010-11-01 |
| Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection (NCT01114425) | Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux | 2010-11-01 |
| Acceptability Study of Vaginal Films for HIV Prevention (NCT01231763) | University of Pittsburgh | 2010-11-01 |